Neogenomics (NEO) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Neogenomics (NEO) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.57% |
| Mar 31, 2026 | 5.01% |
| Dec 31, 2025 | -21.44% |
| Sep 30, 2025 | -66.01% |
| Jun 30, 2025 | -45.89% |
| Mar 31, 2025 | -30.01% |
| Dec 31, 2024 | -34.70% |
| Sep 30, 2024 | -59.30% |
| Jun 30, 2024 | -62.59% |
| Mar 31, 2024 | -62.02% |
| Dec 31, 2023 | -111.76% |
| Sep 30, 2023 | -61.99% |
| Jun 30, 2023 | -43.60% |
| Mar 31, 2023 | -69.33% |
| Dec 31, 2022 | -70.03% |
| Sep 30, 2022 | -39.74% |
| Jun 30, 2022 | -74.92% |
| Mar 31, 2022 | -67.65% |
| Dec 31, 2021 | -24.08% |
| Sep 30, 2021 | -29.28% |